Is NCT07507422 recruiting in Phoenix, AZ?

Yes, NCT07507422 is currently recruiting participants at its Phoenix, AZ location. This chronic pain clinical trial is actively enrolling qualified participants.

How do I join the chronic pain clinical trial in Phoenix?

To join this clinical trial in Phoenix, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Phoenix clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Chronic Pain Clinical Trial in Phoenix, AZ

Who Can Participate

Inclusion Criteria

18 years of age or older

Patient must be SCS therapy naïve

A clinical decision was made for the patient to receive an Inceptiv™ SCS system (pending satisfactory results from a Medtronic SCS trial) limited to on-label leads based on the specific geography for an on-label indication prior to enrollment in the study.

Patient is on stable opioid dosage for 3 months prior to enrollment, if applicable

Pain intensity of ≥ 6 as measured using the NPRS (0-10) in the predominant area(s) of pain that SCS is intended to treat

Patient must have an on-label indication specific to geography.

NOTE: Patients may be enrolled if they have upper limb radicular limb pain, related or unrelated to spine surgery

NOTE: In the US, patients experiencing chronic back pain without a history of spine surgery and not eligible for spine surgery are on-label candidates for SCS if the pain is associated with degenerative disc disease, herniated disc, or radicular pain syndrome. Radicular pain syndrome (with or without prior spine surgery) is an approved indication for SCS implant.

Diagnosis of chronic back and/or limb pain for an on-label indication lasting at least six months.

Exclusion Criteria

Has any existing or is planning to have a new active implantable neuromodulation device or system during the 5 year follow up period (e.g., peripheral nerve stimulation, sacral neuromodulation, intrathecal drug delivery system, a second SCS system)

Has a complex pain pattern that involves both upper and lower limbs or back and upper limb

Has a planned major medical procedure within 6 months before enrollment or after implant that may interfere with study results or confound results as determined by the Investigator

Has a planned interventional procedure within 6 weeks (+/- 2 weeks) before enrollment or after implant that may interfere with study results or confound results as determined by the Investigator

Major untreated or unstable psychiatric comorbidity, such as suicidal ideations, personality disorders, schizophrenia etc., that could interfere with accurate pain reporting, study procedures, and/or confound evaluation of study, as determined by the Investigator

Subjects with PCS total score \>30 are not eligible unless ALL of the following are met:

Absence of uncontrolled major psychiatric disorder or active suicidality based on clinical evaluation.

Investigator documentation of adequate understanding of therapy, realistic expectations, and anticipated compliance with protocol follow-up

Major non-indicated, untreated or refractory progressive disease (e.g., neurodegenerative disease {not including Diabetic Peripheral Neuropathy}, heart failure, cancer, osteoarthritis, fibromyalgia, chronic fatigue syndrome), or injury (e.g., fall resulting in hip fracture) that could interfere with accurate pain reporting, study procedures, and/or confound evaluation of study as determined by the Investigator

Has inpatient or outpatient admissions for drug or alcohol dependency within past 12 months or current/ongoing substance abuse

Has a current prescription of ≥90 morphine milligram equivalents (MME) per day

Has predominant mechanical back pain arising from facet or sacroiliac joint pain as the main cause of chronic low-back pain if low-back pain is the predominant pain condition, as determined by the Investigator

Has mechanical spine instability (eg. Spondylolisthesis grade 2) as determined by the Investigator

Has an active systemic or local infection that would delay trial or implant

Is pregnant or planning on becoming pregnant

Has a life expectancy of less than 1 year

Involved in an injury claim, under current litigation, beneficiary of an injury claim, receiving worker's compensation, or planning any future litigation

Has a condition that the Investigator determines would significantly increase perioperative risk (e.g., unstable or severe cardiac disease, liver disease, uncontrolled diabetes, kidney disease) Patients enrolled into the study with Diabetic Peripheral Neuropathy, Complex Regional Pain Syndrome and Upper Limb pain are required to meet further inclusion/exclusion criteria in order to contribute to the analysis for that particular condition. These criteria are designed to ensure that the patient's condition aligns with the standard diagnostic criteria set by applicable clinical guidelines. Painful Diabetic Peripheral Neuropathy (DPN) Inclusion Criteria

Clinical diagnosis of diabetes mellitus according to the American Diabetes Association guidelines (ADA).

Predominant pain condition being treated by SCS is lower-limb pain due to DPN

Hemoglobin A1c (HbA1c) must be \<8% within 6 months of enrollment for inclusion or have completed a preoperative risk assessment if \>8%

Presence of either numbness or at least one sensory disturbance (e.g., increased or decreased sensitivity, burning, pricking/stabbing, aching, "pins and needle" sensation) in the foot/feet. Painful DPN Exclusion Criteria

Lower-limb pain not associated with DPN or that cannot be distinguished from DPN (e.g., mononeuropathies, proximal neuropathies, nonneuropathic pain, peripheral vascular disease)

History of lower-limb amputation or planned lower-limb amputations due to diabetes

Large (≥3cm) and/or gangrenous ulcers or active infection of the lower limbs Complex Regional Pain Syndrome (CRPS) Inclusion Criteria

Meets diagnostic criteria for CRPS (International Association for the Study of Pain "Budapest Criteria")

Disease that is clinically restricted to one hand or foot and affects the entire hand, foot or lower extremity

CRPS is the predominant pain condition that SCS is intended to treat CRPS Exclusion Criteria

Presence of Reynaud's disease

Current or previous neurologic abnormalities unrelated to CRPS

Another condition affecting the function of the diseased or contralateral extremity

Dystonia as a predominant component of their presentation Upper Limb Pain (ULP) - non CRPS Inclusion Criteria

Be diagnosed with radicular pain syndrome, or be diagnosed with radicular pain secondary to failed back surgery or herniated disk ULP - non CRPS Exclusion Criteria

Has significant cervical stenosis, as determined by the Investigator

Failed treatments of carpal tunnel syndrome and/or cubital tunnel syndrome

Has mechanical neck pain (e.g., facet spondylosis), as determined by the Investigator

Any previous history of surgery on the posterior elements (laminectomy, posterior fusion) of the cervical spine

Has brachial plexus injury as predominant cause of pain

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Phoenix?

Yes, this clinical trial (NCT07507422) has an active research site in Phoenix, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Pain Treatment Options in Phoenix, AZ

If you're searching for chronic pain treatment options in Phoenix, AZ, this clinical trial (NCT07507422) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic pain specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic pain clinical trials near you to find additional studies recruiting in your area.

Chronic Pain Clinical Trial in Phoenix, AZ

Expert Care in Phoenix

IRB Approved

No-Cost Care

Apply for This Phoenix Location

Why Participate?

Simple Process

About This Chronic Pain Study in Phoenix